A reported fiery exchange between JPMorgan's Jamie Dimon and Coinbase's Brian Armstrong at the World Economic Forum lays bare the intensifying battle between traditional finance and the crypto industry over regulation, deposits, and the future of money.
While investor attention fixates on flashier names, Marvell Technology's critical role in custom AI chips and data center infrastructure positions it for explosive growth, making its current valuation a potential opportunity.
Investment firm Tanager Wealth Management has fully divested its position in Centessa Pharmaceuticals, capitalizing on the biotech's near-60% annual surge. The move highlights strategic portfolio rebalancing as the stock's rally potentially amplified its risk profile within a diversified fund.
An analysis of wealth accumulation among the world's top billionaires reveals staggering gains during the current presidential term, with policy and market dynamics fueling unprecedented fortunes.
The visual discovery platform Pinterest is cutting up to 15% of its global workforce as part of a strategic shift toward AI development, a move that has reignited concerns among its user base about the proliferation of AI-generated images flooding the platform.
While both ETFs target the high-flying U.S. technology sector, a closer look reveals critical distinctions in diversification, concentration risk, and liquidity that could sway long-term portfolio outcomes.
Beyond their legendary rivalry in the truck market, Ford and General Motors are delivering substantial value to shareholders through distinct but equally compelling financial strategies.
Peter Mandelson, former UK ambassador to Washington, has resigned from the Labour Party following the release of US court documents detailing financial links to the late financier and convicted sex offender Jeffrey Epstein.
After years of sluggish sales and brand challenges, Starbucks is betting on a dual strategy: deploying AI to streamline operations while reinvesting in the in-store experience. CEO Brian Niccol outlines the plan he believes will restore growth and community connection.
Amid a steep 60% annual share price decline, investment firm Chicago Capital has significantly reduced its position in PROCEPT BioRobotics, a developer of robotic systems for urological surgery, signaling a portfolio risk reassessment.
Meta CEO Mark Zuckerberg's forecast of a major AI infrastructure build-out through 2026 suggests continued robust spending on Nvidia's hardware, reinforcing the chipmaker's central role in the ongoing tech boom.
The iconic outdoor retailer Eddie Bauer is preparing to file for Chapter 11 bankruptcy, a move that will close its entire fleet of roughly 200 physical stores across the U.S. and Canada. While its e-commerce and wholesale operations will live on, the decision marks a dramatic retreat from the mall landscape it helped define for decades.
Peter Mandelson, a pivotal figure in the Blair-era Labour Party, has resigned his membership following fresh allegations concerning his ties to the late financier Jeffrey Epstein, marking another blow to the party's establishment.
A looming partial government shutdown highlights critical nuances in prediction market contracts, with Polymarket and Kalshi odds soaring as procedural delays in Congress turn betting specifics into the central story.
The Biden administration has approved a major arms sale to Israel, featuring attack helicopters and armored vehicles, amid a fragile ceasefire in Gaza and ongoing scrutiny over U.S. military support.
Exclusive testimony from Dr. Mohamed Ibrahim, who fled the last hospital in Sudan's strategic el-Fasher, details a three-day ordeal of hiding from paramilitary forces, witnessing mass casualties, and surviving a kidnapping and ransom demand—shedding light on a siege the U.N. calls a 'massive crime scene.'
While America's coffee consumption hits multi-decade highs, Starbucks' market share is eroding. The pioneer now faces a crowded battlefield of value-focused rivals, drive-thru specialists, and international entrants, forcing a strategic rethink of its iconic 'third place' model.
New long-term results from the pivotal EMBARK trial indicate ELEVIDYS, Sarepta's gene therapy, continues to alter the disease trajectory for boys with Duchenne muscular dystrophy, with no new safety concerns emerging over three years.
Amid a brutal year for apparel stocks, Deckers Outdoor delivered a stunning earnings beat, sending shares soaring 19%. The performance of its HOKA and UGG brands, coupled with raised guidance, suggests Wall Street's pessimism may have been overblown for this long-term winner.
In a revealing moment during Tesla's earnings call, Elon Musk disclosed that his Saturdays are dedicated to the company's next-generation AI5 chip project, signaling a fundamental strategic shift from automaker to vertically integrated AI hardware powerhouse.
